Kimberly J Gorden

EGFR inhibitors as first-line therapy in EGFR mutation-positive patients with NSCLC

J. Kolesar, Kimberly J Gorden, Parvin Mesbah, 2012, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.